PWM
BSX icon

Parkworth Wealth Management’s Boston Scientific BSX Stock Holding History

Parkworth Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$4.08K Buy
38
+28
+280% +$2.83K ﹤0.01% 189
2025
Q1 		$1.01K Hold
10
– – ﹤0.01% 257
2024
Q4 		$893 Buy
+10
New +$880 ﹤0.01% 302

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkworth Wealth Management's BSX Position: Q2 2025 in Review

Parkworth Wealth Management increased its Boston Scientific (BSX) stake by 280% in Q2 2025, buying an estimated $2.83K and bringing the position to 38 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #189.

Parkworth Wealth Management first reported a position in BSX in Q4 2024 and has held it in 3 quarters since. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Parkworth Wealth Management held 38 shares of Boston Scientific worth $4.08K as of Q2 2025.
  • Parkworth Wealth Management bought 28 Boston Scientific shares in Q2 2025, an estimated $2.83K.
  • Boston Scientific made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #189 holding.
  • Parkworth Wealth Management first reported a position in Boston Scientific in Q4 2024 and has held it in 3 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.